Valuation: Roopa Industries Limited

Market Cap 359M 3.75M 3.29M 3.11M 2.83M 5.3M 5.34M 37.19M 14.41M 184M 14.08M 13.78M 590M P/E 2025
19.8x
P/E 2026 371x
Enterprise Value 669M 6.98M 6.13M 5.79M 5.27M 9.87M 9.94M 69.23M 26.81M 342M 26.21M 25.64M 1.1B EV / Sales 2025
0.58x
EV / Sales 2026 0.48x
Free-Float
36.13%
Yield 2025 *
-
Yield 2026 -
1 day+1.56%
1 week+3.60%
Current month-4.79%
1 month-10.39%
3 months-4.05%
6 months+5.47%
Current year+3.77%
1 week 40.71
Extreme 40.71
46.85
1 month 40.71
Extreme 40.71
52.5
Current year 38.1
Extreme 38.1
63.4
1 year 38.1
Extreme 38.1
63.4
3 years 38.1
Extreme 38.1
114.9
5 years 15.3
Extreme 15.3
114.9
10 years 6.82
Extreme 6.82
114.9
Manager TitleAgeSince
Chief Executive Officer 72 31/12/1997
Director of Finance/CFO - 30/06/2020
Compliance Officer - 31/05/2022
Director TitleAgeSince
Chairman 72 31/12/1997
Director/Board Member 70 16/03/1997
Director/Board Member 54 25/08/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+3.60%-16.51%+7.68% 3.75M
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average +0.48%+1.02%+25.97%+44.49% 363.84B
Weighted average by Cap. +0.02%+1.32%+41.54%+67.83%

Financials

2025 2026
Net sales 1.21B 12.64M 11.09M 10.48M 9.55M 17.87M 18M 125M 48.56M 619M 47.47M 46.44M 1.99B 1.28B 13.31M 11.68M 11.03M 10.05M 18.82M 18.95M 132M 51.13M 652M 49.98M 48.9M 2.09B
Net income 20.35M 212K 186K 176K 160K 300K 302K 2.11M 816K 10.4M 797K 780K 33.41M 831K 8.67K 7.61K 7.19K 6.55K 12.26K 12.35K 85.99K 33.3K 425K 32.55K 31.85K 1.36M
Net Debt 299M 3.12M 2.74M 2.58M 2.35M 4.41M 4.44M 30.92M 11.98M 153M 11.71M 11.45M 491M 310M 3.23M 2.83M 2.68M 2.44M 4.57M 4.6M 32.03M 12.41M 158M 12.13M 11.87M 508M
Logo Roopa Industries Limited
Roopa Industries Limited is an India-based active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is focused on its core business Triphenyl Phosphine (TPP) and its allied products. Its products include N,N- Dicyclohexylcarbodiimide (DCC); TPP; 5-Cyano Phthalide, and bromine and its derivatives. TPP is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins and others. TTP are more used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to agriculture and others. Glucosamine is a sheet anchor product of the Company, which is a nutraceutical/nutritional supplement. It has capabilities to deliver bromine and bromine compounds of any quantity and specifications, such as Meta Bromo Anisole, Tetra Butyl Ammonium Bromide, 1-Bromo-3-Chloropropane, 1-Acetoxy Ethyl Bromide and others, which are used in chemical and pharmaceutical industry.
Employees
56
Date Price Change Volume
25/09/26 ₹45.70 +1.56% 34
24/09/26 ₹45.00 +0.18% 401
23/09/26 ₹44.92 +4.08% 3,167
22/09/26 ₹43.16 +0.51% 1,162
21/09/26 ₹42.94 -2.65% 3,134
  1. Stock Market
  2. Stocks
  3. ROOPAIND6 Stock